Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

AIMS/HYPOTHESIS: Current drug labels for thiazolidinediones (TZDs) warn of increased fractures, predominantly for distal fractures in women. We examined whether exposure to TZDs affects hip fracture in women and men and compared the risk to that found with other drugs used in diabetes. METHODS: Usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Colhoun, H. M., Livingstone, S. J., Looker, H. C., Morris, A. D., Wild, S. H., Lindsay, R. S., Reed, C., Donnan, P. T., Guthrie, B., Leese, G. P., McKnight, J., Pearson, D. W. M., Pearson, E., Petrie, J. R., Philip, S., Sattar, N., Sullivan, F. M., McKeigue, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464390/
https://www.ncbi.nlm.nih.gov/pubmed/22945303
http://dx.doi.org/10.1007/s00125-012-2668-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464390/
https://www.ncbi.nlm.nih.gov/pubmed/22945303
http://dx.doi.org/10.1007/s00125-012-2668-0

Ejemplares similares